374Water Inc. Form 10-Q Summary
Business Context and Reporting Period
This unaudited Form 10-Q covers the quarter and nine months ended September 30, 2021. On April 16, 2021, the company completed a reverse merger with privately held 374Water, Inc., changed its name from PowerVerde, Inc., and shifted its focus to developing and commercializing supercritical water oxidation systems, including AirSCWO units. The company has not generated material revenue from its planned principal operations.
Key Financial Metrics
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Revenue | $19,000, versus $32,763 in 2020 | $33,600, versus $32,763 in 2020 |
| Net income (loss) | $(551,959), versus $73,767 | $(2,492,817), versus $72,872 |
| Operating expenses | $571,387, versus $8,996 | $2,527,168, versus $11,891 |
| Net loss per share | $(0.01), versus $0.00 | $(0.03), versus $0.00 |
| Cash used in operating activities | Not separately presented | $(1,053,591), versus $78,584 provided |
Gross profit and gross margin are not clearly provided because reported revenue was primarily from service and assembly activities and the filing does not present a cost-of-revenue line. Operating margin was substantially negative due to limited revenue and elevated development and public-company costs.
- Cash was $6.85 million at September 30, 2021, compared with $71,799 at December 31, 2020.
- Working capital was $6.80 million, compared with $10,572 at December 31, 2020.
- Total assets were $7.98 million, including a $1.06 million Duke University license intangible asset.
- Total liabilities were $100,142. The filing reports no outstanding debt at September 30, 2021.
- Stockholders’ equity was $7.88 million, compared with $11,250 at December 31, 2020.
- The company had 122,817,746 common shares outstanding at September 30 and November 1, 2021.
Material Changes Versus the Prior Comparable Period
- Revenue declined 42% in the third quarter but increased modestly for the nine-month period, reflecting limited consulting, advisory, and manufacturing assembly activity.
- Research and development expense increased to $269,796 for the nine months from $1,740, primarily due to engineering activity after the merger.
- General and administrative expense increased to $612,387 from $7,486, primarily due to insurance, payroll, stock-based compensation, and public-company costs.
- Professional fees increased to $245,152 from $2,665, primarily due to merger-related legal and accounting work and ongoing public-company requirements.
- Product development expense was $1.40 million, compared with none in the prior-year period, representing the fair value of warrants issued to a strategic partner for AirSCWO product development, manufacturing, supply, and service arrangements.
- The company raised gross proceeds of approximately $6.55 million through Series D convertible preferred stock and received $1.29 million from option and warrant exercises.
- Preferred stock issued in April was substantially converted into common stock: 412,853 preferred shares converted into 20,642,667 common shares, leaving 27,272 preferred shares outstanding at September 30.
- Common shares outstanding increased from 62,410,452 at December 31, 2020 to 122,817,746 at September 30, 2021, creating substantial dilution risk.
Guidance, Outlook, Risks, and Unusual Items
Management expects substantial net losses to continue until the company successfully commercializes and markets its systems, but provides no quantified revenue, profitability, or commercialization guidance. Management believes existing funds will satisfy working-capital needs for at least the next 12 months; however, it cautions that additional financing may be required and may not be available on commercially reasonable terms or at all.
- The company’s principal technology is licensed from Duke University under a worldwide license agreement. Future royalties are payable on licensed product sales and sublicensing fees, and the company must reimburse ongoing patent expenses. No license-related expense had been incurred through September 30, 2021.
- The Duke license was recorded at $1.07 million, with a 17-year estimated life and $15,787 of amortization recognized during the quarter and nine-month period.
- Potentially dilutive securities excluded from diluted loss per share included options for 12,596,000 common shares and 1,363,600 shares issuable upon conversion of remaining Series D preferred stock.
- Management concluded that disclosure controls and internal control over financial reporting were ineffective. Reported material weaknesses included insufficient management review, inadequate segregation of duties and accounting resources, and ineffective entity-level controls, including the absence of an audit committee.
- Key business risks include research and development execution, commercialization uncertainty, patent protection and enforcement, competition, financing needs, regulatory and economic changes, and interest-rate and market fluctuations.
- The filing reports no legal proceedings, defaults, or market-risk disclosures requiring presentation.
Important Facts for Investors to Verify
- Verify the company’s commercialization timetable, customer pipeline, unit economics, and expected timing of material AirSCWO revenue.
- Assess the cash burn rate and whether the $6.85 million cash balance is sufficient for planned development and operating needs.
- Review the terms, conversion rights, liquidation preference, voting rights, and remaining balance of the Series D preferred stock.
- Evaluate dilution from outstanding options, remaining preferred-stock conversion rights, and future equity financing.
- Monitor remediation of the disclosed material weaknesses in internal controls and the establishment of effective board and audit-committee oversight.
- Review the Duke license’s royalty obligations, patent-expense requirements, termination provisions, and the company’s ability to maintain the license.